Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Kathleen Ogilvie
John D. Mendlein
Date of Patent
September 26, 2023
Patent Application Number
16499979
Date Filed
April 19, 2018
Patent Citations
...
Patent Primary Examiner
Patent abstract
Provided are therapies, including combination therapies, for the treatment of lung inflammation, including interstitial lung diseases (ILDs), which include the use of at least one histidyl-tRNA synthetase (HRS) polypeptide or an expressible polynucleotide that encodes the HRS polypeptide, alone or in combination with at least one immunomodulatory agent.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
